Thursday, October 15, 2009

Mkt and Stem Cells up Again Thursday 10.15

Thursday 10.15.09:
DOW +47(.47%) @10,063..NAS +1.06(.05%) @2,173.. SP500 +4.54(.42%) @1,097

BIO-Stem Index:+1.51(1.03%) @148.15 (+48.15% ytd) +2% since last post on Monday
BIO-ETF Index:+1.31(1.17%) @114.34 (+14.34% ytd) +2.3% since Monday

The market was up slightly up Thursday, but biotechs and stem cells put in 1% gains overall.

Stem Cell Stocks (19 up, 10 down, 1 nc)
Big Winners:ARIA +4.3%, ATHX +4.6%, CRIS +7.7%, STEM +5.8%
Losers: OSIP -3.8%

Swine Flu Stocks
AVII nc, BCRX +3.4%, DVAX -.55%, GILD +1.26%, INHX +1.9%, INO +2%, NVAX +3.2%, SIGA +.9%, SVA +.6%
Other Flu: APT -1%, CVM +25%, GNBT -7.4%,

Other Biotech
Big Winners: ALTH +4%, CBI +9.4%, CLDX +4.2%, CRXX +5.9%, IMMU +8.4%, ISTA +6%, JAZZ +11.2%, KVA +6.7%, PLX +5.5%, SVNT +5.8%, TRIB +3.6%
Losers: DYAX -6.5%, JAV -6.7%, ONCY -7.1%, QGLY -4.7%, RGEN -4.1%,
SubMicro: KOOL +8.9%, NEXM +9.3%, PRAN -5.9%

Disclosure: Long DNDN

Monday, October 12, 2009

Mkt Flat, Stem Cells Up Monday 10.12

Monday 10.12.09:
DOW +21(.2%) @9,886..NAS -.14(.01%) @2,139.. SP500 ?? @1,076

BIO-Stem Index:+1.21(.85%) @145.21 (+45.21% ytd)
BIO-ETF Index:+.35(.03%) @111.75 (+11.75% ytd)

The market was slightly up on Monday, but our stem cell index rose .85%, while the ETFs were barely up, .03%

Stem Cell Stocks (13 up, 17 down, 1 nc)
Big Winners:DNDN +4.5%, GERN +6.4%, PSTI +3.6%
Losers: NUVA -5.5%

Swine Flu Stocks
AVII -2.2%, BCRX -5.4%, DVAX -4.4%, GILD -.26%, INHX -.9%, INO -1.3%, NVAX -8.7%, SIGA -.5%, SVA -4.1%
Other Flu: APT -.75%, GNBT +6.9%, HEB -3.7%, QDEL -5%, VICL -4%

Other Biotech
Big Winners: CRME +4.2%, DCTH +5.6%, ELRN +6.8%, KERX +5.8%, ONCY +7.8%, ONXX +5.1%, PPDI +4.6%, VVUS +4%
Losers: AEZS -4.2%, AVNR -9.8%, INSM -4.8%, POZN -3.9%, RPRX -4.8%, XOMX -5.9%

SubMicro: ENMD -14.5%, TGEN +10.2%, TRBN -7.9%, YMI +6.6%

Disclosure: Long DNDN

Thursday, October 8, 2009

Mkt Up, Biotech Flat on Thursday 10.08

Thursday 10.08.09:
DOW +61(.6%) @9,787..NAS +13.6(.64%) @2,124.. SP500 +7.9(.75%) @1,065

BIO-Stem Index:-.07(.01%) @142.92 (+42.92% ytd)
BIO-ETF Index:-.46(.4%) @111.05 (+11.06% ytd)

The market regained momentum Thursday, .75%. Stem cells were flat, biotechs were off a half percent.

Stem Cell Stocks (18 up, 11 down, 2 nc)
Big Winners:AFFX +6.8%
Losers: ASTM -5.5%, AVII -3.7%, OPXA -4.1%

Swine Flu Stocks
AVII -3.7%, BCRX -1.95%, DVAX +1.8%, GILD -.2%, INHX +8.5%, INO -1.3%, NVAX nc, SIGA -1.4%, SVA -1.5%
Other Flu: APT +6.9%, HEB +12.7%, VICL -4%

Other Biotech
Big Winners: ANDS +7.2%, BSDM +5.3%, IMGN +4.6%, MED +4.2%, SNTX +4.4%
Losers: AVNR -4.9%, CPD -4.3%, CTIC -5.3%, HGSI -4%, LXRX -4.3%, PARD -8.3%, PGNX -7.5%, QGLY -13.4%, RPRX -27.4%, SGEN -4.5%, SVNT -11.8%

SubMicro: ENMD +63%, TGEN -10.5%, VSCI +6.6%

New Intraday Highs:AFFX, APT, CBI, MDVN, SNTS, SNY, WYE, ENMD

Disclosure: Long DNDN

Wednesday, October 7, 2009

Mkt, Biotech Pause on Wednesday 10.07

Wednesday 10.07.09:
DOW -5.7(.06%) @9,725..NAS +6.8(.32) @2,110.. SP500 +2.9(.27%) @1,057

BIO-Stem Index:-.41(.3%) @142.92 (+42.93% ytd)
BIO-ETF Index:-.45(.4%) @111.52 (+11.52% ytd)

The market paused on Wednesday, flat today after two days of 1% jumps. Biotechs were off a little more than the market, but only slightly. RPRX jumped 109% after positive testing on a drug that increases testosterone - the story is here

Stem Cell Stocks (12 up, 19 down)
Big Winners:AVII +5%, CRIS +3.9%, SQNM +11.2%
Losers: ASTM -9.3%

Swine Flu Stocks
AVII +5%, BCRX -.4%, DVAX -2.3%, GILD -.9%, INHX -6%, INO -4.4%, NVAX -1.7%, SIGA -1.7%, SVA -.55%
Other Flu: APT +8%, CVM +6.5%, HEB +2.4%, PURE +2.4%

Other Biotech
Big Winners: ADLR +5.9%, AVNR +13.6%, CTIC +16.3%, PLX +4.3%, QGLY +8.1%, RPRX +109%, SOMX +9.4%
Losers: ACAD -4.2%, ANDS -6.75%, CGEN -9.2%, CRXX -4.4%, JAV -8.3%, SGMO -9.8%

SubMicro: GETA -7.8%, GTCB -7.8%, HEPH +10.1%, ONSM +6.2%, THLD +14.6%, YMI -4.4%

New Intraday Highs:APT, DVA, SLXP, WYE

Disclosure: Long DNDN

Tuesday, October 6, 2009

Mkt and Biotech Up 1% More Tuesday 10.06

Tuesday 10.06.09:
DOW +112(1.2%) @9,600..NAS +20(1%) @2,068..SP500 +15(1.5%) @1,040

BIO-Stem Index:+1.68(1.2%) @143.34 (+43.34% ytd)
BIO-ETF Index:+1.29(1.2%) @111.97 (+11.97% ytd)

The market rallied over 1% more on Tuesday - biotech followed in line with both stem cells and biotech ETFs up 1.2%.

Stem Cell Stocks (23 up, 8 down)
Big Winners:AFFX +7.8%, CUR +3.5%, OSTE +4.2%,
Losers: AVII -5.7%, OPXA -5.8%, PSTI -13.6%

Swine Flu Stocks
AVII -5.7%, BCRX -.5%, DVAX nc, GILD +1.6%, INHX -1%, INO -2.4%, NVAX -2.7%, SIGA +2.5%, SVA -3.3%
Other Flu: APT +2%, CRXL +1.2%, CVM -14.8%, HEB -6.1%, PURE +3.1%

Other Biotech
Big Winners: ACAD +15.2%, ALTH +6.3%, ELRN +10.9%, INSM +5.9%, OXGI +5.3%, PGNX +6.2%, PLX +4.4%, POZN +4.6%, SLXP +4.8%, SVNT +4.6%,
Losers: ANDX -5.6%, CRXX -8.7%, CTIC -10.1%, DSCO -4.5%, IMMU -4%, MAXY +7.3%, XOMX -5.3%,

SubMicro: VSCI -6.9%

New Intraday Highs:ILMN, SLXP, SNTS, WYE

Disclosure: Long BCRX, BSDM, CVM, DNDN

Monday, October 5, 2009

Mkt and Stem Cells Rally Monday 10.05

Monday 10.05.09:
DOW +112(1.2%) @9,600..NAS +20(1%) @2,068..SP500 +15(1.5%) @1,040

BIO-Stem Index:+3.50(2.5%) @141.65 (+41.65% ytd)
BIO-ETF Index:+.35(.3%) @110.68 (+10.68% ytd)

The market rallied over 1% Monday, while our stem cell index surged 2.5%, easily beating the biotech ETFs, which were up only .3%. AVII jumped 23% after getting a government contract for 11.5 million from the Defense Threat Reduction Agency, but the stock is still 1/3 off its 52-wk high.

Stem Cell Stocks (19 up, 12 down)
Big Winners:AVII +23.1%, CRIS 3.5%, OPXA +3.2%
Losers: OSIR -4.8%, SQNM -1.95%

Swine Flu Stocks
AVII +23.1%, BCRX nc, DVAX +6.2%, GILD +1.1%, INHX -2.9%, INO -2.4%, NVAX +7%, SIGA +4.4%, SVA +3.2%
Other Flu: CVM -2.4%, GNBT +5.4%, HEB -4.3%, PURE +6%, VICL +3.3%

Other Biotech
Big Winners: AVNR +6.2%, CRXX +17.2%, CYPB +4%, DYAX +5.1%, ENZN +5.5%, HGSI +5.1%, IMMU +5.5%, KVA +4.8%, MED +8.8%, NGSX +6.1%, NKTR +4.7%, RPRX +10.1%, SNTS +7.2%, SUPG +5.2%
Losers: CLDX -5%, CTIC -4.4%, MAXY -4%, NVGN -4.2%, ONCY -6.5%, SCLN -10.1%, SGEN -14.6%

SubMicro: ENMD +10%, FMTI +6%

Disclosure: Long BCRX, BSDM, CVM, DNDN

Friday, October 2, 2009

Mkt, Biotech Down Slightly Friday 10.02

Friday 10.02.09:
DOW -21(.2%) @9,488..NAS -9(.46%) @2,048..SP500 -4.6(.45%) @1,025

BIO-Stem Index: -1.21(-.87%) @138.15 (+38.15% ytd)
BIO-ETF Index: -.59(-.54%) @110.33 (+10.34% ytd)

The market dropped a fraction on Friday, losing just a half percent overall. Biotech fell about as much, stem cells a little more, .87%, with only 8 up, 23 down. Trimeris (TMRS) rose 37% on a takeover. ONCY as up 20% after an FDA agreement to conduct Phase 3 trials on head and neck cancers with their platinum based therapy, which show 42% response rate and 75% clinical benefit rate in Phase 2 data from the U.K, to be released in detail in late 2009.

Stem Cell Stocks (8 up, 23 down)
Big Winners: ABT 2.4%, ALXN 2.2%, OSIR 3.65%
Losers: AVII -4.3%, CUR -2.7%, OPXA -7.3%, SQNM -5.2% (the fall continues...)

Swine Flu Stocks
AVII -4.3%, BCRX +7.3%, DVAX -3.6%, GILD -1.7%, INHX -.9%, INO +11.2%, NVAX -6.3%, SIGA +.9%, SVA -4.6%
Other Flu: APT -3.3%, CRXL -1%, CVM -7.3%, HEB +2%, PURE -3.2%, VICL -2.7%

Other Biotech
Big Winners: ACAD +4.4%, AEZA +4.2%, CLDX +4.2%, KERX +8.2%, ONCY +20.4%, SLXP +3.5%
Losers: ADLR -3.2%, ANIK -3.7%, BDSM -3.5%, CGEN -5.3%, CPD -3%, CTIC -5.8%, DSCO -11.6%, GTXI -7.6%, IMMU -4.1%, INSM -3.1%, LTRX -4.1%, MATK -3.7%, MED -3%, NBIX -3.4%, NVGN -10.9%, QGLY -3.5%, VVUS -3.9%

SubMicro: CPRX -18%, GETA -14%, ORXE +7%, PMD -7.5%, TGX -4.3%, THLD +4.4%, TRMS +37%

New Intraday Highs: SLXP

Disclosure: Long BCRX, BSDM, CVM, DNDN

Thursday, October 1, 2009

Mkt and Biotech Plunge 2-3% Thursday 10.01

Thursday 10.01.09:
DOW -203(2.1%) @9,509..NAS -65(3.1%) @2,057..SP500 -27(2.6%) @1,030

BIO-Stem Index:-5.27(-3.65%) @149.36 (+39.36% ytd)
BIO-ETF Index:-3.45(-3%) @110.93 (+10.93% ytd)

The market plunged today after Bernanke said that the government may have to regulate the biggest financial institutions more closely (as if we didn't know already); the typical capitalist reaction to any regulations is of course panic. They also like to 'send a message' to the white house my making prices plunge on any threat of honesty or sound business practices, which hampers the collusion and corruption in the system. As a result, the stem cell index fell 3.65%, with only one rising (SQNM, a paltry .6% gain), it's worst daily loss since we created it, while the biotech ETFs fell 3% as well. The BCRX rise after hours last night was a fake-out, as it not only failed to carry through the gains but fell 6% - so much for 'good news' helping investors.

Stem Cell Stocks (1 up, 30 down)
Big Losers: AFFX -5%, ARIA -5.9%, ATHX -6.6%, AVII -5.2%, CRIS -15%, CUR -5.1%, CYTX -6.3%, DNDN -4.7%, OSIR -5.4%

Swine Flu Stocks
AVII -5.3%, BCRX -6.3%, DVAX -7.7%, GILD -2.6%, INHX +4.9%, INO -3.2%, NVAX -7.6%, SIGA -7.8%, SVA -8.3%
Other Flu: APT +3.8%, CRXL -3.9%, CVM +4.1%, HEB -8%, PURE -4.3%, QDEL -4.7%, VICL -5.9%

Other Biotech
Winners: BDSI +1%, NVGN +3.9%,
Big Losers: ACAD -7.6%, ALNY -5%, ARQL -5.1%, AVNR -5.8%, DSCO -11%, DYAX -11.7%, ELRN -5.1%, EXEL -6.4%, GTXI -7%, IMGN -6.7%, IMMU -10.7%, KERX -11.1%, KNDL -5.3%, KVA -6.2%, LXRX -8.5%, MED -7.8%, RPRX -10%, SGEN -5.9%, SGMO -6.7%, SOMX -8.1%, SPPI -5.6%, SUPG -5.2%, VRTX -9.7%, VVUS -5.7%

SubMicro: CPRX +39%, GETA +10%, GTCB -5%, TGX -11.9%, TRMS +5.2%, YMI +4.6%

Disclosure: Long BCRX, BSDM, CVM, DNDN

Disclaimer

This is not a solicitation or recommendation to buy or sell any stock. We are not registered investment advisors, and the site does not receive any compensation for any posts, endorsements, or listings. All investments carry risk, and your own individual situation should determine your strategy. Only invest funds you can afford to lose.

The Author at EZines

STEM CELLS EXPRESS

Visitor Map

Related Sites

World Markets Summary

Why We Invest

A company issuing stock gets it's money when the stock goes public, called IPO for Initial Public Offering. However, if the stock takes off due to future expectations, the company can capitalize by issuing more stock and raising money near the current price, so investing in these small biotech companies increases their chances of succeeding by raising enough additonal capital that they don't need to take on debt.

Then when promising drugs are approved and released, the subsequent income produced drives the stock price higher, and all investors and employees benefit and can either invest more in the industry or perhaps realize a goal in life.

1000 DVDs to See

About Me

My Photo
Artist, photographer, composer, author, blogger, metaphysician
©2009, William L. Sinclair, All Rights Reserved

  © Blogger template 'Froggy' by Ourblogtemplates.com 2008

Back to TOP